News

Mainstay Medical announces half year financial results

on 28/08/2014 16:20
Momentum builds towards commercialisation of ReActiv8®
Read more

Nexstim progresses its navigated brain stimulation technology in stroke and demonstrates improved outcomes in brain tumor surgery

on 28/08/2014 10:21
Study on track and sites selected and initiated in multicenter clinical trial on the therapeutic effects of NBT® for stroke rehabilitation.
Read more

iSTAR Medical appoints Michel Vanbrabant Chief Executive Officer

on 16/07/2014 11:40
iSTAR Medical SA announced today that Michel Vanbrabant has been appointed Chief Executive Officer and member of the Board of Directors.
Read more

Mainstay Medical Announces Pre-IDE Submission for ReActiv8® to FDA

on 07/07/2014 11:26
Mainstay Medical continues progress towards the commercialisation of ReActiv8.
Read more

AG Insurance invests € 5 million in the Capricorn ICT Arkiv

on 04/07/2014 16:24
Capricorn Venture Partners and AG Insurance have just announced that AG Insurance will be investing € 5 million in Capricorn ICT Arkiv.
Read more